# Detection of Covid-19 by Volatile Organic Compounds in Exhaled Breath

> **NCT04714333** · — · UNKNOWN · sponsor: **British Columbia Cancer Agency** · enrollment: 1000 (estimated)

## Conditions studied

- Covid19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04714333
- **Lead sponsor:** British Columbia Cancer Agency
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-06
- **Primary completion:** 2021-05-05
- **Final completion:** 2021-05-05
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2021-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04714333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04714333, "Detection of Covid-19 by Volatile Organic Compounds in Exhaled Breath". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04714333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*